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Introduction
Anxiety is the psychological process by which
the individual reacts to dangerous external stimuli,
triggering responses (mediated by norepinephrine,
GABA and serotonin) involving physiological reac-
tions and cognitive strategies. Anxiety can be dif-
ferentiated in state anxiety and trait anxiety. The
state anxiety is the activation of a state of alarm at
the time of the stimulus, regardless of the presence
of a basic personological anxious, while the trait
anxiety is a permanent personality trait.
Whenever they have significant stimuli the
subject using a stimulus-response model marked by
anxiety. In general, anxiety is characterized by an
unpleasant state of inner turmoil, often accompa-
nied by nervous behavior, such as pacing back and
forth, somatic complaints, and rumination. Anxiety
is different from fear, because it is properly the
expectation of future threat, and feeling of uneasi-
ness and worry. Many chronic pediatric condition
may provoke anxiety and other internalizing prob-
lems in parents of affected children(1-10). 
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ABSTRACT
Introduction: Anxiety is the psychological process by which the individual reacts to dangerous external stimuli, triggering
responses (mediated by norepinephrine, GABA and serotonin) involving physiological reactions and cognitive strategies. Anxiety can
be differentiated in state anxiety and trait anxiety. 
Fragile X Syndrome (FXS) is a disorder most commonly caused by a triplet repeat expansion of >200 cytosine-guanine-guani-
ne (CGG) repeats in the 50 untranslated region of the Fragile X mental retardation 1 (FMR1) gene.
Aim of the present study is investigating the state or trait anxiety in a sample of mothers of children affected by X-fragile.
Materials and methods: 84 mothers (mean age 48.36 ± 7.11) of children affected by FXS were recruited and compared with
mother of 171 typical developing children (mean age 46.18 ± 9.53). The Scale State-Trait Anxiety Inventory for Adults (STAI) was
used in order to assess the anxiety levels. 
Results: All mothers of children affected by FXS showed high score of anxiety levels at the STAI evaluation (Table 1), with no
differences were found between mothers of males and females children affected. 
Conclusions: Mothers of children with FXS appear to be in a state of anxiety effects and suddenly even higher than those
found later in mothers of children with other chronic diseases.
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Fragile X Syndrome (FXS) is a disorder most
commonly caused by a triplet repeat expansion of
>200 cytosine-guanine-guanine (CGG) repeats in
the 50 untranslated region of the Fragile X mental
retardation 1 (FMR1) gene(11-12).
Aim of the present study is investigating the state or
trait anxiety in a sample of mothers of children
affected by X-fragile.
Materials and methods
84 mothers (mean age 48.36 ± 7.11) of chil-
dren affected by FXS were recruited and compared
with mother of 171 typical developing children
(mean age 46.18 ± 9.53).
Exclusion criteria were the following: over-
weight (z-BMI> 85 pc) and obesity (z-BMI > 95
pc), cognitive disability (IQ <70), neurological dis-
orders (ie headaches, epilepsy), chromosomal syn-
dromes different from FXS (eg. Down, Prader-
Willi, Crouzon, Pierre-Robin, trisomy 18), psychi-
atric illness (ie. mood disorders, anxiety disorders,
psychosis) and specific neuropsychological disor-
ders(13-38).
Anxiety levels assessment
The Scale State-Trait Anxiety Inventory for
Adults (STAI) consists of 40 items, split into 2 mul-
tiple choice subscales of 20 items each. The first
questionnaire measure states anxiety (S-anxiety),
consisting of questions that address how respon-
dents feel at the moment, including items that mea-
sure subjective feelings of calm, tension, apprehen-
sion, nervousness, worry, and other questions that
assess autonomic nervous system activity. State
anxiety scale items are rated on a 4 point Likert
scale (1 = not at all, 2 = somewhat, 3 = moderately
so, and 4 = very much so). The second subscale
measures trait anxiety (T-anxiety), on how respon-
dents generally feel, using items that measure gen-
eral states of calmness, security, and confidence.
Items were rated on a 4 point Likert scale (1 =
almost never, 2 = sometimes, 3 = often, and 4 =
almost always). The total STAI score for each sub-
scale (S-anxiety and T-anxiety) is the addition of
response scores for the 20 items, and ranges from
20-80, with higher scores indicating greater anxiety.
The scores consent to distinguish different grades
of anxiety levels: mild (20-40 points), moderate
(41-60 points), severe (61-80 points). A score below
20 is indicative for the absence of anxiety.
Results
In our study, all mothers of children affected
by Down syndrome showed high score of anxiety
levels at the STAI evaluation. By comparison with
the control population reveals the presence of sig-
nificantly more prevalent anxiety levels of moder-
ate and severe in mothers of children with X-
Fragile Syndrome. (Table 1). Specifically, there was
a distribution of different levels of anxiety: 27
mothers showed mild anxiety was (32.15% vs
66.66%, p <0.001); 31 mothers showed moderate
anxiety was (36.9% vs. 5.21%, p = 0.011); 26
mothers showed severe anxiety was (30.95% vs
28.12%, p <0.001). 32 mothers showed mild anxi-
ety tract (38.09% vs. 71.34%, p <0.001); 35 moth-
ers showed moderate anxiety tract (41.66% vs.
18.71%, p <0.001); 17 mothers showed severe anx-
iety trait (20:23% vs. 9.94%, p = 0.038). (Table 1).
No differences were found between mothers of
males and females children affected. 
Discussion
Anxiety, like all emotional reactions, has an
adaptive function, crucial for survival. When this
chronically, anxiety has nevertheless a strong
impact on the life of the subject. It first reduces the
capacity for action, then it becomes pathological
anxiety. Our data, like those reported in the litera-
ture, highlighting the difficulty of mothers of chil-
dren with Fragile syndrome to accept and manage
the disease, although to varying degrees and with
different characteristics from disease pathology(39-47). 






levels % 32.15 66.66 <0.001
Moderate state
anxiety levels % 36.9 21.05 0.011
Severe state anxiety
levels % 30.95 12.28 <0.001
Mild trait anxiety
levels % 38.09 71.34 <0.001
Moderate trait
anxiety levels % 41.66 18.71 <0.001
Severe trait anxiety
levels % 20.23 9.94 0.038
Table 1: shows comparison between pathological per-
centages scores between different anxiety grades among
mothers of children affected by FragileX syndrome
(FXS) and those of normal children (Controls). Chi-
square test was applied. p values <0.05 were considered
as statistically significant.
About FXS, the objective difficulties that
these mothers encounter in the management of their
children, it also adds to the marginalization and
social prejudice that still reign. The social and emo-
tional contacts were generally normal, although it
was required greater empathy. The families were
involved and usually controlled and experiences
generally positive. We have seen, however, the
result of the study we conducted and performed on
a larger sample of the population has in fact contra-
dicted this first observation. The mothers of chil-
dren with FXS appear to be in a state of anxiety
effects and suddenly even higher than those found
later in mothers of children with other chronic dis-
eases(39-50). 
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